Although existing studies have shown somewhat correlation between the occurrence of liver cancer and the level of IL-6, the clinical relationship between the level of IL-6 promoter methylation and HBV-associated HCC has not yet been tested (29). This evidence concerns the gene IL6 and hepatocellular carcinoma.